Clinical Trials Directory

Trials / Unknown

UnknownNCT04338568

Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study

Accuracy and Inter-observer Variability of Lung Ultrasound in COVID-19 Pneumonia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be normal, and early low-dose CT-scan is advocated to diagnose viral pneumonia. Lung ultrasound (LUS) has similar diagnostic properties as CT for diagnosing pneumonia. However, it has the advantage that it can be performed at point-of-care, minimizing the need to transfer the patient, reducing the number of health care personnel and equipment that come in contact with the patient and thus potentially decrease the risk of spreading the infection. This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLung ultrasoundThe lung ultrasound examination consists of two-sided scanning of the anterior and lateral chest wall and is performed with patients in supine or near-to-supine position.

Timeline

Start date
2020-04-16
Primary completion
2020-11-30
Completion
2020-12-30
First posted
2020-04-08
Last updated
2020-08-17

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04338568. Inclusion in this directory is not an endorsement.